{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:48:53Z","timestamp":1789858133310,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s11926-013-0327-1","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T02:13:21Z","timestamp":1364177601000},"source":"Crossref","is-referenced-by-count":29,"title":["Infectious Complications in Juvenile Idiopathic Arthritis"],"prefix":"10.1007","volume":"15","author":[{"given":"Andrew","family":"Hurd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Beukelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"issue":"2","key":"327_CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pcl.2012.03.014","volume":"59","author":"PJ Gowdie","year":"2012","unstructured":"Gowdie PJ, Tse SM. Juvenile idiopathic arthritis. Pediatr Clin N Am. 2012;59(2):301\u201327. Epub 2012\/05\/09.","journal-title":"Pediatr Clin N Am"},{"issue":"9783","key":"327_CR2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138\u201349. Epub 2011\/06\/21.","journal-title":"Lancet"},{"issue":"4","key":"327_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465\u201382. Epub 2011\/04\/01.","journal-title":"Arthritis Care Res"},{"issue":"9","key":"327_CR4","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3899\/jrheum.120110","volume":"39","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Ringold S, Davis TE, DeWitt EM, Pelajo CF, Weiss PF, et al. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J Rheumatol. 2012;39(9):1867\u201374. Epub 2012\/08\/04.","journal-title":"J Rheumatol"},{"issue":"3","key":"327_CR5","first-page":"387","volume":"35","author":"AL Smitten","year":"2008","unstructured":"Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008;35(3):387\u201393. Epub 2008\/02\/09.","journal-title":"J Rheumatol"},{"issue":"9","key":"327_CR6","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46(9):2287\u201393. Epub 2002\/10\/02.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 5","key":"327_CR7","doi-asserted-by":"crossref","first-page":"v38","DOI":"10.1093\/rheumatology\/kes114","volume":"51","author":"A Rubbert-Roth","year":"2012","unstructured":"Rubbert-Roth A. Assessing the safety of biologic agents in patients with rheumatoid arthritis. Rheumatology. 2012;51 Suppl 5:v38\u201347. Epub 2012\/06\/29.","journal-title":"Rheumatology"},{"issue":"9","key":"327_CR8","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002;46(9):2294\u2013300. Epub 2002\/10\/02.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"327_CR9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/kem076","volume":"46","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, Hudson M, Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology. 2007;46(7):1157\u201360. Epub 2007\/05\/05.","journal-title":"Rheumatology"},{"issue":"7","key":"327_CR10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","volume":"71","author":"WG Dixon","year":"2012","unstructured":"Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, et al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis. 2012;71(7):1128\u201333. Epub 2012\/01\/14.","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"327_CR11","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","volume":"306","author":"CG Grijalva","year":"2011","unstructured":"Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, et al. Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA: J Am Med Assoc. 2011;306(21):2331\u20139. Epub 2011\/11\/08.","journal-title":"JAMA: J Am Med Assoc"},{"issue":"5","key":"327_CR12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.2010.128637","volume":"70","author":"K Au","year":"2011","unstructured":"Au K, Reed G, Curtis JR, Kremer JM, Greenberg JD, Strand V, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(5):785\u201391. Epub 2011\/02\/04.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"327_CR13","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"\u2022\u2022 Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(8):2773\u201380. Epub 2012\/05\/10. This study of administrative claims data demonstrated an increased background risk of serious bacterial infection among children with JIA, in the absence of systemic immunosuppressant therapy. This study also demonstrated no significant increased risk of infection associated with methotrexate or TNFi use, but did show a significant increased risk with high doses of oral glucocorticoids.","journal-title":"Arthritis Rheum"},{"key":"327_CR14","doi-asserted-by":"crossref","unstructured":"\u2022 Beukelman T, Xie F, Baddley JW, Chen L, Delzell E, Grijalva CG, et al. Incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum. 2013;[accepted for publication 27 Dec 2012]. This study of administrative claims data demonstrated an increased rate of opportunistic infections among children with JIA compared to children without JIA.","DOI":"10.1002\/art.37866"},{"issue":"5","key":"327_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.autrev.2010.02.015","volume":"11","author":"C Mayerl","year":"2012","unstructured":"Mayerl C, Prelog M. Immunosenescence and juvenile idiopathic arthritis. Autoimmun Rev. 2012;11(5):297\u2013300. Epub 2010\/02\/23.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"327_CR16","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.20128","volume":"62","author":"MY Smith","year":"2010","unstructured":"Smith MY, Sobel RE, Wallace CA. Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry. Arthritis Care Res. 2010;62(6):800\u20134. Epub 2010\/06\/11.","journal-title":"Arthritis Care Res"},{"issue":"11","key":"327_CR17","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/art.27670","volume":"62","author":"N Ruperto","year":"2010","unstructured":"Ruperto N, Giannini EH, Pistorio A, Brunner HI, Martini A, Lovell DJ. Is it time to move to active comparator trials in juvenile idiopathic arthritis?: a review of current study designs. Arthritis Rheum. 2010;62(11):3131\u20139. Epub 2010\/07\/28.","journal-title":"Arthritis Rheum"},{"key":"327_CR18","doi-asserted-by":"crossref","unstructured":"\u2022 Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, et al. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(9):2794\u2013804. Epub 2009\/08\/29. This prospective, observational study revealed no significant difference in the rates of medically important infections among children with JIA treated with the combination of etanercept and methotrexate, or etanercept alone, or methotrexate alone.","DOI":"10.1002\/art.24777"},{"key":"327_CR19","doi-asserted-by":"crossref","unstructured":"\u2022 Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis. 2009;68(4):519\u201325. Epub 2008\/04\/17. This prospective, observational study demonstrated no significant difference in the rate of serious infections among children with JIA treated with the combination of etanercept and methotrexate versus etanercept alone.","DOI":"10.1136\/ard.2007.087593"},{"issue":"5","key":"327_CR20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","volume":"58","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008;58(5):1496\u2013504. Epub 2008\/04\/29.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"327_CR21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","volume":"51","author":"K Minden","year":"2012","unstructured":"Minden K, Niewerth M, Zink A, Seipelt E, Foeldvari I, Girschick H, et al. Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO. Rheumatology. 2012;51(8):1407\u201315. Epub 2012\/03\/27.","journal-title":"Rheumatology"},{"issue":"9","key":"327_CR22","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","volume":"56","author":"N Ruperto","year":"2007","unstructured":"Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2007;56(9):3096\u2013106. Epub 2007\/09\/01.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"327_CR23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.2009.100354","volume":"69","author":"N Ruperto","year":"2010","unstructured":"Ruperto N, Lovell DJ, Cuttica R, Woo P, Meiorin S, Wouters C, et al. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Ann Rheum Dis. 2010;69(4):718\u201322. Epub 2010\/03\/20.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"327_CR24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","volume":"359","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008;359(8):810\u201320. Epub 2008\/08\/22.","journal-title":"N Engl J Med"},{"issue":"2","key":"327_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MD.0b013e318211106a","volume":"90","author":"MA Lane","year":"2011","unstructured":"Lane MA, McDonald JR, Zeringue AL, Caplan L, Curtis JR, Ranganathan P, et al. TNF-alpha antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis. Medicine. 2011;90(2):139\u201345. Epub 2011\/03\/02.","journal-title":"Medicine"},{"issue":"8","key":"327_CR26","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/ard.2010.146365","volume":"70","author":"JR Curtis","year":"2011","unstructured":"Curtis JR, Xie F, Chen L, Baddley JW, Beukelman T, Saag KG, et al. The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents. Ann Rheum Dis. 2011;70(8):1401\u20136. Epub 2011\/05\/19.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"327_CR27","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/acr.21805","volume":"64","author":"JR Curtis","year":"2012","unstructured":"Curtis JR, Xie F, Chen L, Muntner P, Grijalva CG, Spettell C, et al. Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients. Arthritis Care Res. 2012;64(10):1480\u20139. Epub 2012\/07\/27.","journal-title":"Arthritis Care Res"},{"issue":"9636","key":"327_CR28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","volume":"372","author":"N Ruperto","year":"2008","unstructured":"Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Perez N, Silva CA, et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet. 2008;372(9636):383\u201391. Epub 2008\/07\/18.","journal-title":"Lancet"},{"issue":"6","key":"327_CR29","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/art.27431","volume":"62","author":"N Ruperto","year":"2010","unstructured":"Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Perez N, Silva CA, et al. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum. 2010;62(6):1792\u2013802. Epub 2010\/03\/02.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"327_CR30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","volume":"70","author":"D Salmon-Ceron","year":"2011","unstructured":"Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, et al. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis. 2011;70(4):616\u201323. Epub 2010\/12\/24.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"327_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jbspin.2010.12.004","volume":"78","author":"L Baronnet","year":"2011","unstructured":"Baronnet L, Barnetche T, Kahn V, Lacoin C, Richez C, Schaeverbeke T. Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint Bone Spine: Rev Rhum. 2011;78(3):279\u201384. Epub 2011\/01\/29.","journal-title":"Joint Bone Spine: Rev Rhum"},{"issue":"5","key":"327_CR32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012;64(5):625\u201339. Epub 2012\/04\/05.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"327_CR33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archinte.163.4.487","volume":"163","author":"AM Fendrick","year":"2003","unstructured":"Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163(4):487\u201394. Epub 2003\/02\/18.","journal-title":"Arch Intern Med"},{"issue":"4","key":"327_CR34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.rdc.2012.08.016","volume":"38","author":"KH Dao","year":"2012","unstructured":"Dao KH, Herbert M, Habal N, Cush JJ. Nonserious infections: should there be cause for serious concerns? Rheum Dis Clin N Am. 2012;38(4):707\u201325. Epub 2012\/11\/10.","journal-title":"Rheum Dis Clin N Am"},{"issue":"6","key":"327_CR35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.2010.144741","volume":"70","author":"WG Dixon","year":"2011","unstructured":"Dixon WG, Kezouh A, Bernatsky S, Suissa S. The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study. Ann Rheum Dis. 2011;70(6):956\u201360. Epub 2011\/02\/03.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"327_CR36","first-page":"774","volume":"28","author":"C Scott","year":"2010","unstructured":"Scott C, Meiorin S, Filocamo G, Lanni S, Valle M, Martinoli C, et al. A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2010;28(5):774\u201381. Epub 2010\/09\/25.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"327_CR37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0049-0172(81)90001-9","volume":"10","author":"RG Gray","year":"1981","unstructured":"Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum. 1981;10(4):231\u201354. Epub 1981\/05\/01.","journal-title":"Semin Arthritis Rheum"},{"key":"327_CR38","volume-title":"Red book: 2012 report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2012","unstructured":"American Academy of Pediatrics. In: Pickering LK, editor. Red book: 2012 report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012.","edition":"29"},{"issue":"2","key":"327_CR39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.autrev.2011.08.010","volume":"11","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, Ott de Bruin LM, Borrow R, van der Klis F, Kone-Paut I, Fasth A, et al. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations. Autoimmun Rev. 2011;11(2):112\u201322. Epub 2011\/09\/08.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"327_CR40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22399","volume":"56","author":"E Zonneveld-Huijssoon","year":"2007","unstructured":"Zonneveld-Huijssoon E, Ronaghy A, Van Rossum MA, Rijkers GT, van der Klis FR, Sanders EA, et al. Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis. Arthritis Rheum. 2007;56(2):639\u201346. Epub 2007\/02\/01.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"327_CR41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.vaccine.2011.11.083","volume":"30","author":"L Dell'Era","year":"2012","unstructured":"Dell'Era L, Corona F, Daleno C, Scala A, Principi N, Esposito S. Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. Vaccine. 2012;30(5):936\u201340. Epub 2011\/12\/06.","journal-title":"Vaccine"},{"issue":"31","key":"327_CR42","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1016\/j.vaccine.2010.03.080","volume":"28","author":"E Farmaki","year":"2010","unstructured":"Farmaki E, Kanakoudi-Tsakalidou F, Spoulou V, Trachana M, Pratsidou-Gertsi P, Tritsoni M, et al. The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis. Vaccine. 2010;28(31):5109\u201313. Epub 2010\/05\/18.","journal-title":"Vaccine"},{"issue":"3","key":"327_CR43","first-page":"436","volume":"30","author":"N Toplak","year":"2012","unstructured":"Toplak N, Subelj V, Kveder T, Cucnik S, Prosenc K, Trampus-Bakija A, et al. Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2012;30(3):436\u201344. Epub 2012\/04\/20.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"327_CR44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcma.2011.03.004","volume":"74","author":"M Erguven","year":"2011","unstructured":"Erguven M, Kaya B, Hamzah OY, Tufan F. Evaluation of immune response to hepatitis A vaccination and vaccine safety in juvenile idiopathic arthritis. J Chin Med Assoc: JCMA. 2011;74(5):205\u20138. Epub 2011\/05\/10.","journal-title":"J Chin Med Assoc: JCMA"},{"issue":"1","key":"327_CR45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3899\/jrheum.110721","volume":"39","author":"NE Aikawa","year":"2012","unstructured":"Aikawa NE, Campos LM, Silva CA, Carvalho JF, Saad CG, Trudes G, et al. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. J Rheumatol. 2012;39(1):167\u201373. Epub 2011\/11\/18.","journal-title":"J Rheumatol"},{"issue":"7","key":"327_CR46","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/acr.20183","volume":"62","author":"GS Pileggi","year":"2010","unstructured":"Pileggi GS, de Souza CB, Ferriani VP. Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids. Arthritis Care Res. 2010;62(7):1034\u20139. Epub 2010\/03\/18.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"327_CR47","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2006.063586","volume":"66","author":"MW Heijstek","year":"2007","unstructured":"Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E, Armbrust W, Hoppenreijs EP, Uiterwaal CS, et al. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis. 2007;66(10):1384\u20137. Epub 2007\/02\/08.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"327_CR48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","volume":"48","author":"S Borte","year":"2009","unstructured":"Borte S, Liebert UG, Borte M, Sack U. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology. 2009;48(2):144\u20138. Epub 2008\/12\/17.","journal-title":"Rheumatology"},{"issue":"1","key":"327_CR49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.12739","volume":"308","author":"J Zhang","year":"2012","unstructured":"Zhang J, Xie F, Delzell E, Chen L, Winthrop KL, Lewis JD, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA: J Am Med Assoc. 2012;308(1):43\u20139. Epub 2012\/07\/05.","journal-title":"JAMA: J Am Med Assoc"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0327-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-013-0327-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0327-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T05:19:32Z","timestamp":1562822372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-013-0327-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1007\/s11926-013-0327-1","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]},"article-number":"327"}}